The economic value of reducing mortality due to noncommunicable diseases and injuries
Authors' conclusion
Despite the large uncertainty surrounding our estimates, we offer economic values for reducing avoidable mortality by cause and metrics comparable to annual incomes
Study context
- Population
- Geographic regions, with high-income countries, India and China considered separately
- Outcome
- Economic value of reducing avoidable mortality from major noncommunicable diseases and injuries
- Follow-up
- 2000, 2019 and 2050
Methodological detailsPart of the World Bank Healthy Longevity Initiative, Avoidable mortality = difference between lowest-achieved mortality frontiers and projected mortality trajectories, per cause of death; economic values applied
- Part of the World Bank Healthy Longevity Initiative
- Avoidable mortality = difference between lowest-achieved mortality frontiers and projected mortality trajectories, per cause of death; economic values applied
Main finding
As reported in the abstract
Economic value of reducing avoidable mortality, as % of annual income · 2019
CVD: large for both sexes in all regions
2-8% of annual income
Cancers: high-income countries and China
5-6% of annual income
Injuries: sub-Saharan Africa and Latin America and the Caribbean
around 5%
Original publication
The economic value of reducing mortality due to noncommunicable diseases and injuries. Nat Med. Published 27 September 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →